Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Fujimura

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Case Reports in Nephrology|November 29, 2014
Postoperative atypical hemolytic uremic syndrome associated with complement c3 mutationEiji Matsukuma, Atsushi Imamura, Yusuke Iwata, et al.
Plos One|March 20, 2012
Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from JapanMasanori Matsumoto, Charles L Bennett, Ayami Isonishi, et al.
Pediatric Nephrology (Berlin, Germany)|October 24, 2006
Intravenous gamma globulin for thrombotic microangiopathy of unknown etiologyShuichi Ito, Kenichi Okuyama, Tomoko Nakamura, et al.
Blood|July 19, 2003
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavageKenji Soejima, Masanori Matsumoto, Koichi Kokame, et al.
Blood Advances|November 8, 2019
Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndromeYoshihiro Fujimura, Bernhard Lämmle, Saori Tanabe, et al.
Molecular Genetics & Genomic Medicine|June 18, 2014
Candidate gene analysis using genomic quantitative PCR: identification of ADAMTS13 large deletions in two patients with Upshaw-Schulman syndromeYuka Eura, Koichi Kokame, Toshiro Takafuta, et al.
Journal of Atherosclerosis and Thrombosis|September 6, 2019
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute PhaseSatoko Sakurai, Hideki Kato, Yoko Yoshida, et al.
Pediatric Blood & Cancer|May 1, 2013
Limited renal prophylaxis in regular plasmatherapy for heritable ADAMTS13 deficiencyTakehiko Doi, Shouichi Ohga, Naoko Ito, et al.
Journal of Atherosclerosis and Thrombosis|April 8, 2016
Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve ReplacementKeigo Yamashita, Hideo Yagi, Masaki Hayakawa, et al.
Blood|December 14, 2002
SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injectionJianfeng Wang, Takafumi Kimura, Rumiko Asada, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Case Reports in Nephrology|November 29, 2014
Postoperative atypical hemolytic uremic syndrome associated with complement c3 mutationEiji Matsukuma, Atsushi Imamura, Yusuke Iwata, et al.
Plos One|March 20, 2012
Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from JapanMasanori Matsumoto, Charles L Bennett, Ayami Isonishi, et al.
Pediatric Nephrology (Berlin, Germany)|October 24, 2006
Intravenous gamma globulin for thrombotic microangiopathy of unknown etiologyShuichi Ito, Kenichi Okuyama, Tomoko Nakamura, et al.
Blood|July 19, 2003
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavageKenji Soejima, Masanori Matsumoto, Koichi Kokame, et al.
Blood Advances|November 8, 2019
Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndromeYoshihiro Fujimura, Bernhard Lämmle, Saori Tanabe, et al.
Molecular Genetics & Genomic Medicine|June 18, 2014
Candidate gene analysis using genomic quantitative PCR: identification of ADAMTS13 large deletions in two patients with Upshaw-Schulman syndromeYuka Eura, Koichi Kokame, Toshiro Takafuta, et al.
Journal of Atherosclerosis and Thrombosis|September 6, 2019
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute PhaseSatoko Sakurai, Hideki Kato, Yoko Yoshida, et al.
Pediatric Blood & Cancer|May 1, 2013
Limited renal prophylaxis in regular plasmatherapy for heritable ADAMTS13 deficiencyTakehiko Doi, Shouichi Ohga, Naoko Ito, et al.
Journal of Atherosclerosis and Thrombosis|April 8, 2016
Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve ReplacementKeigo Yamashita, Hideo Yagi, Masaki Hayakawa, et al.
Blood|December 14, 2002
SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injectionJianfeng Wang, Takafumi Kimura, Rumiko Asada, et al.
Pageof 18